Page last updated: 2024-09-04

cryptotanshinone and Body Weight

cryptotanshinone has been researched along with Body Weight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hu, G; Ni, X; Qi, C; Sun, Z; Wang, L; Yang, L; Yang, Y1
Chen, L; Wang, H; Wang, HJ; Xie, W; Yao, Y; Zhang, YS1

Other Studies

2 other study(ies) available for cryptotanshinone and Body Weight

ArticleYear
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF‑κB signaling pathway.
    Molecular medicine reports, 2020, Volume: 22, Issue:5

    Topics: Animals; Body Weight; Cell Proliferation; Cell Survival; Disease Models, Animal; Female; Gene Expression Regulation; HMGB1 Protein; NF-kappa B; Organ Size; Phenanthrenes; Polycystic Ovary Syndrome; Rats; Signal Transduction; Toll-Like Receptor 4

2020
Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo.
    Molecular medicine reports, 2014, Volume: 9, Issue:6

    Topics: Animals; Apoptosis; Body Weight; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Lung Neoplasms; Mice; Phenanthrenes; Tumor Burden; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2014